PRFX Painreform Ltd
Company Analysis
Latest News
🔴 Painreform is trading 8% down today amid Nasdaq and S&P 500 declines
Painreform is trading 8.36% lower at $0.70, consistent with weaker broad-market sentiment. - The Nasdaq Composite is down 1.63% and the S&P 500 is down 0.84%,...
🟢 Painreform is trading 8.39% up today amid broader biotech gains
Painreform is trading at $0.78, up 8.39%, with a biotech sector rally offering a possible supporting context. - No new company-specific announcement was...
🟢 Painreform is trading 17.4% up in pre-market
Painreform is trading at $0.85 (+17.44%) in pre-market, with no new company-specific announcement identified to explain the move. - The company’s...
🟢 Painreform is trading 7.55% up on October 20, 2026 with biotech sector up 2.10%
Painreform is trading at $0.79, up 7.55%, with the biotech sector’s 2.10% gain potentially supporting the move. - No company-specific announcement explaining...
🔴 Painreform is trading 10.42% down with no confirmed catalyst
Painreform is trading 10.42% down at $0.70, with no direct catalyst confirmed. - The decline follows a $0.78 close on October 16, when the stock was already...
🔴 Painreform is trading 6% down as biotech weakness offers partial context
Painreform is trading at $0.78 (-6.01%) as biotech-sector weakness is the likeliest available context, though it does not fully explain the decline. - No new...
🔴 Painreform is trading 5% down today amid broader biotech weakness
Painreform is trading 5.22% down at $0.82, amid broader biotech weakness, though available evidence does not establish a direct cause for the October 13...
🟢 Painreform is trading 5.5% up in pre-market; catalyst remains unverified
Painreform is trading at $0.93, 5.5% up in pre-market; the reason for the move remains unverified. - The stock closed at $0.88 on October 6 after several...
🟢 Painreform is trading 6.78% up in pre-market with no verified catalyst identified
Painreform is trading at $0.94, up 6.78% in pre-market on October 6, 2026, with no verified catalyst identified. - Painreform closed at $0.88 on October 5. -...
🟢 Painreform is trading 5.28% up in after-hours trading with no verified company-specific catalyst identified
Painreform is trading at $1.03 (+5.28%) after the regular session closed on September 24, 2026, with the catalyst still unclear. - Searches found no verified...
🟢 Painreform is trading 11.85% up today driven by biotech-sector strength
Painreform is trading 11.85% higher at $1.05 during the active September 23, 2026 session; the move appears primarily sector-driven. - Biotech is up 2.07%,...
🟢 Painreform is trading 7.5% up today on biotech-sector strength
Painreform is trading 7.47% higher at $1.00, with broader biotech strength lifting the sector. - Biotech rose 2.07% during regular trading, and trading remains...
🟢 Painreform is trading 5.3% up in pre-market as biotech sector rises 2.61% pre-market
Painreform is trading 5.3% up at $0.98, with broader biotech-sector strength the most likely explanation for the move. - The price compares with the September...
🟢 Painreform is trading 6.4% up in after-hours trading with no verified company-specific announcement
Painreform is trading at $0.99, up +6.39%, after rising after regular-session trading ended; no verified September 22, 2026 company-specific announcement...
🔴 Painreform is trading 5.9% down today — catalyst remains unclear
Painreform is trading at $0.96, down 5.9%, after falling from the September 18 close of $1.02; the catalyst remains unclear. - The decline is occurring...
🟢 Painreform is trading 5.33% up in pre-market — no verified company-specific catalyst identified
Painreform is trading at $1.07 (+5.33%) in pre-market with no confirmed direct explanation identified. - No verified company-specific announcement dated...
🟢 Painreform is trading 10.89% up today as indexes and biotech stocks advance
Painreform is trading 10.89% up now at $1.12, as broad risk appetite supports higher-beta stocks and major U.S. indexes and biotech stocks advance after...
🔴 Painreform is trading 5.9% down in pre-market on September 17, 2026; no verified company-specific catalyst
Painreform is trading at $0.95 (-5.88%) in pre-market on September 17, 2026, with no reliable company-specific announcement identified to explain the...
🔴 Painreform is trading 5.7% down in after-hours trading following a Federal Reserve rate hike
Painreform is trading at $0.95, down 5.73% in after-hours trading as broader markets remained cautious following the Federal Reserve rate hike. - Painreform...
GridFeed's AI Data-Center Pitch Lifts PainReform 11%, but Can Buzzwords Alone Sustain a Dollar Stock?
Shares of PainReform Ltd (PRFX) jumped 11% to $1.00 on September 16 after its subsidiary PRF Technologies announced that its GridFeed AI energy platform is...